Health Care & Life Sciences » Pharmaceuticals | Jin Yang Pharmaceutical Co. Ltd.

Jin Yang Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
40,235
45,237
40,149
36,132
43,450
Cost of Goods Sold (COGS) incl. D&A
16,439
17,470
18,080
19,037
20,755
Gross Income
23,795
27,766
22,069
17,096
22,695
SG&A Expense
18,854
21,581
23,044
26,969
27,838
EBIT
4,824
6,064
1,124
9,998
5,614
Unusual Expense
316
1,048
152
55
757
Non Operating Income/Expense
541
323
48
364
569
Interest Expense
4
10
38
337
428
Pretax Income
5,487
5,092
1,059
9,968
7,319
Income Tax
1,295
1,079
55
869
1,551
Consolidated Net Income
4,193
4,013
1,004
9,099
5,768
Net Income
4,193
4,013
1,004
9,099
5,768
Net Income After Extraordinaries
4,193
4,013
1,004
9,099
5,768
Net Income Available to Common
4,193
4,013
1,004
9,099
5,768
EPS (Basic)
367.00
355.00
90.00
814.00
516.00
Basic Shares Outstanding
11
11
11
11
11
EPS (Diluted)
366.97
354.93
89.77
814.02
516.06
Diluted Shares Outstanding
11
11
11
11
11
EBITDA
5,814
7,019
97
8,447
3,618
Other Operating Expense
117
121
149
125
471
Non-Operating Interest Income
443
408
206
59
49

About Jin Yang Pharmaceutical Co.

View Profile
Address
231 Hyoryeong-ro
Seoul SL 06671
Korea, Republic Of
Employees -
Website http://www.jinyangpharm.com
Updated 09/14/2018
JIN YANG PHARMACEUTICAL Co., Ltd. engages in the pharmaceutical business. Its products includes medicines for digestive system, respiratory system, antihistamines, antipyretics & analgesics, antimicrobials & antibiotics, muscle relaxants, neuropsychiatric system, anti-hypertensives, anti-hyperlipidemics, anti-diabetics, circulatory system, injections, dermatological system, multivitamins & nutritionals, anti-obesity, hepatics, anti-anemics, anti-osteoporosis, genito-urinary system, dental care drugs, and ophthalmic drugs. The company was founded on July 1, 1971 and is headquartered in Seoul, South Korea.